Proactive Investors - Run By Investors For Investors

GW Pharmaceuticals RNS Release

Total Voting Rights

RNS Number : 8957N
GW Pharmaceuticals PLC
31 October 2016



GW Pharmaceuticals PLC ("GW Pharmaceuticals")




Cambridge, UK, 31 October 2016: In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, GW Pharmaceuticals plc ("GW" or "the Company") (AIM:GWP, NASDAQ:GWPH) confirms that the Company's issued share capital consists of 302,458,090 ordinary shares of 0.1p each in issue, each with equal voting rights. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.


For further information, please contact:


GW Pharmaceuticals PLC                                 +44 (0)1980 557 000

Adam George, Company Secretary    


Peel Hunt LLP (Nominated Adviser)

James Steel/Oliver Jackson                                          60;     +44 (0) 20 7418 8900

This information is provided by RNS
The company news service from the London Stock Exchange

GW Pharmaceuticals Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use